APP and neuroblastoma: As we could not obtain a selective antibody against TAT, we performed this experiment in a mouse neuroblastoma cell line in which APP is knocked out (N2a-APPKO; Figure 3F,G) to allow selective identification of exogenously applied TAT-AICD-NLS or TAT-AICD-NES using the APP antibody Y188.